Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | RORA | P35398 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | RORB | Q92753 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 6/20 | 0.33 |
| ▸ | RXRA | P19793 | 5/20 | 0.33 |
| ▸ | RXRG | P48443 | 2/20 | 0.32 |
| ▸ | ICMT | O60725 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601617 | 0.95 | PGR (0.35) | KIF11SERPINE1PGRRORARORC | |
| SCHEMBL24601612 | 0.95 | PGR (0.36) | KIF11SERPINE1PGRRORARORC | |
| SCHEMBL24601622 | 0.95 | KIF11 (0.36) | KIF11SERPINE1PGRRORARORC | |
| SCHEMBL24601460 | 0.94 | RXRB (0.36) | KIF11SERPINE1PGRRORARORC | |
| SCHEMBL24601419 | 0.94 | RXRB (0.36) | KIF11SERPINE1PGRRORARORC | |
| SCHEMBL24601417 | 0.91 | RXRB (0.36) | KIF11RXRBRXRARXRGEGFR | |
| SCHEMBL24601345 | 0.91 | RXRB (0.36) | KIF11RXRBRXRARXRGEGFR | |
| SCHEMBL24601441 | 0.90 | HTR1D (0.35) | SERPINE1PGRRORARORCRORB | |
| SCHEMBL24601483 | 0.90 | RXRB (0.36) | SERPINE1RXRBRXRARXRGICMT | |
| SCHEMBL24601347 | 0.88 | RXRB (0.37) | KIF11SERPINE1RXRBRXRARXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | KIF11 3347/4885SERPINE1 4819/4885PGR 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.